The development of chemotherapy drugs has promoted anticancer treatment, but the effect
on tumours is not clear because of treatment resistance; thus, it is necessary to further …

Cancer stem cells (CSCs) are a small subpopulation of cells within a tumor that can both self‐
renew and differentiate into other cell types forming the heterogeneous tumor bulk. Since …

Drug resistance is a major problem in cancer treatment. Herein, the design of a dual‐
responsive Pt (IV)/Ru (II) bimetallic polymer (PolyPt/Ru) to treat cisplatin‐resistant tumors in …

Erlotinib-based EGFR targeted therapy has proven significant clinical improvement against
non-small cell lung cancer (NSCLC). However, the anticancer activity of Erlotinib (Ertb) is …

Ovarian cancer rates the highest mortality among all gynecological malignancies. The main
reason for high mortality is the development of drug resistance. It can be related to changes …

Ovarian cancer is characterized by dysbiosis, referred to as oncobiosis in neoplastic
diseases. In ovarian cancer, oncobiosis was identified in numerous compartments, including …

Background Cancer cell membrane-camouflaged nanotechnology for metal complex can
enhance its biocompatibility and extend the effective circulation time in body. The ruthenium …

Simple Summary Regucalcin plays a multifunctional role in the regulation of cell function
and expresses a repressive effect in the growth of normal cells. Of note, there is increasing …

Ovarian cancer is the most lethal neoplasm of the female genital organs. Despite
indisputable progress in the treatment of ovarian cancer, the problems of chemo-resistance …

Simple Summary Patient-specific factors must be thoroughly analyzed to minimize the side
effects of applied treatments. This study examined the radiobiological response of …